Source link : https://www.newshealth.biz/health-news/high-dose-vitamin-d-disappoints-in-metastatic-crc-solaris/
BARCELONA, Spain — The addition of high-dose vitamin D supplementation to standard chemotherapy plus bevacizumab did not result in a significant progression-free survival benefit in patients with metastatic colorectal cancer (CRC) in the SOLARIS study. The researchers did identify a small progression-free survival improvement in patients with left-sided primary tumors, but this should be considered […]
Author : News Health
Publish date : 2024-09-19 12:13:56
Copyright for syndicated content belongs to the linked Source.
inHealth